Lobbying client · LD-2 disclosures
Isis Pharmaceuticals
California
21 filings from 1 registrant · 2010–2016 · latest filed Apr 7, 2016
Reported on its behalf
$295K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$295K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
10 filings
$295K on those filings
Medical/Disease Research/Clinical Labs
MED
10 filings
$295K on those filings
Pharmacy
PHA
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
- H.R. 1249 112th CongressLeahy-Smith America Invents Act5 filingsthrough 2012
- S. 23 112th CongressAmerica Invents Act5 filingsthrough 2012
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Who did the lobbying
Every lobbyist named on this client's filings.
- Stephen M Ryan Mcdermott Will & Schulte LLPCovered position: Deputy Counsel, President's Commission on12 filingsthrough 2013
- Karen Sealander Mcdermott Will & Schulte LLP12 filingsthrough 2013
- David Duane Ransom Mcdermott Will & Schulte LLPCovered position: Member)12 filingsthrough 2013
- Sheila D Walcoff Mcdermott Will & Schulte LLPCovered position: Representatives4 filingsthrough 2010
The filings
The 20 most recent of 21 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: isis-pharmaceuticals.